comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-27 21:55:31 - browse：563

Stock photo of a surgeon holding a digital tablet in a medical setting – health tech coverage from STAT — Adobe

A new $50 million nonprofit initiative aims to independently evaluate health technologies’ impact on costs and quality, an attempt to help patients, payers, and providers sort over-hyped products from ones that actually move the needle.

The Peterson Center on Healthcare, a nonprofit supporting programs that raise care quality and drive down costs, announced the new Peterson Health Technology Institute Tuesday. The institute plans to publish its methodology for assessing new health technology as soon as September, and start publishing reports on specific sectors, like disease types or tech mechanisms, in 2024, executive director Caroline Pearson told STAT.

Especially after digital health investment surged early in the pandemic, health apps and software have proliferated — both those marketed to consumers and designed for organizations like health systems or insurers. Venture funding has since contracted, but customers are still faced with “an overwhelming number of solutions,” Pearson said. “It’s hard to know what is high value in this space.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Why age limits for politicians are a terrible idea

WSS

Bristol 'take

Bill would stop addiction treatment from triggering child abuse inquiry

Trump used to be more articulate. What could explain the change?

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

Colorectal cancer study finds potential in overlooked immune cell

Bill would stop addiction treatment from triggering child abuse inquiry

hotspot

comprehensive

focus

Medicare proposal to cover medical devices draws a mixed reaction

Failure, not just success, should guide future doctors

BioMarin wins approval for gene therapy to treat hemophilia A

Liquid biopsy for lung cancer is launched by Delfi

BioMarin wins approval for gene therapy to treat hemophilia A

Paxlovid rebound happens. Why and to whom are still a mystery

Tori Bowie and the unacceptable rates of Black maternal death

Chemotherapy drug shortage eases slightly but still widespread

Hollywood unions extend contract negotiations for actors

Kansas bar where gunfire wounded 9 last month closes permanently

hotspot

Slovenia has suffered its worst

How CRISPR works, explained in two minutes

Colorectal cancer study finds potential in overlooked immune cell

Doctors push to include dialysis machines in emergency stockpile

It was time to plan for my old age. If only I could stop crying

Senate panel eyes new effort on drug shortages

focus

knowledge

explore

focus